Burrage Capital Management as of June 30, 2021
Portfolio Holdings for Burrage Capital Management
Burrage Capital Management holds 22 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals (BCRX) | 13.7 | $14M | 865k | 15.81 | |
| Intellia Therapeutics (NTLA) | 10.3 | $10M | 64k | 161.91 | |
| Epizyme | 7.0 | $7.0M | 837k | 8.31 | |
| Essa Pharma Com New (EPIX) | 6.8 | $6.8M | 237k | 28.57 | |
| NeoGenomics (NEO) | 6.7 | $6.7M | 148k | 45.17 | |
| Mei Pharma | 6.7 | $6.6M | 2.3M | 2.85 | |
| Crinetics Pharmaceuticals In (CRNX) | 5.6 | $5.6M | 295k | 18.85 | |
| Cytokinetics (CYTK) | 4.9 | $4.8M | 245k | 19.79 | |
| Amicus Therapeutics (FOLD) | 4.8 | $4.8M | 500k | 9.64 | |
| Harmony Biosciences Hldgs In (HRMY) | 4.2 | $4.2M | 150k | 28.23 | |
| Inozyme Pharma (INZY) | 4.1 | $4.1M | 243k | 17.04 | |
| Y Mabs Therapeutics (YMAB) | 3.9 | $3.9M | 115k | 33.80 | |
| Mirum Pharmaceuticals (MIRM) | 3.6 | $3.6M | 206k | 17.29 | |
| Adc Therapeutics Sa SHS (ADCT) | 3.0 | $3.0M | 125k | 24.35 | |
| Verastem | 2.9 | $2.9M | 706k | 4.07 | |
| Merus N V (MRUS) | 2.8 | $2.8M | 131k | 21.07 | |
| Geron Corporation (GERN) | 2.7 | $2.7M | 1.9M | 1.41 | |
| Avrobio Ord (AVRO) | 2.2 | $2.2M | 245k | 8.89 | |
| Revolution Medicines (RVMD) | 1.6 | $1.6M | 50k | 31.74 | |
| Black Diamond Therapeutics (BDTX) | 1.3 | $1.3M | 110k | 12.19 | |
| G1 Therapeutics | 1.0 | $1.0M | 48k | 21.95 | |
| Turning Point Therapeutics I | 0.2 | $169k | 2.2k | 78.10 |
